Skip to Content
Merck
  • Sutureless femtosecond anterior lamellar keratoplasty: a 1-year follow-up study.

Sutureless femtosecond anterior lamellar keratoplasty: a 1-year follow-up study.

Indian journal of ophthalmology (2014-11-06)
Rohit Shetty, Harsha Nagaraja, Himabindu Veluri, Yathish Shivanna, Thungappa Kugar, Rudy Nujits, Bhujang Shetty
ABSTRACT

To study the safety and efficacy of sutureless femtosecond anterior lamellar keratoplasty (FALK) in patients with corneal stromal opacities. Eleven eyes of 11 consecutive patients with corneal stromal opacities involving < 250 μ due to various pathologies were included in the study. Preoperatively, all underwent anterior segment imaging with spectral domain optical coherence tomography (SD-OCT) (Bioptigen Inc., Durham, North Carolina, USA) to measure the depth of the stromal opacity. All patients underwent FALK, and bandage contact lens was placed for a period of 2 weeks. Postoperatively, uncorrected visual acuity, best corrected visual acuity (BCVA), and SD-OCT evaluation were performed. All patients showed significant improvement in BCVA. The mean postoperative BCVA (in decimals) improved from 0.11 ± 0.06 preoperatively to 0.59 ± 0.08. There were no intraoperative or significant postoperative complications that were noticed. FALK is a safe and effective alternative to deep anterior lamellar keratoplasty or penetrating keratoplasty in the treatment of anterior stromal opacities.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Prednisolone 21-acetate, ≥97%
Prednisolone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
Prednisolone acetate, European Pharmacopoeia (EP) Reference Standard
USP
Prednisolone acetate, United States Pharmacopeia (USP) Reference Standard